Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
Latest News
May 17, 2013Pearl Therapeutics Presents Dose-Ranging,...
May 13, 2013Pearl Therapeutics Initiates PT003 Phase 3...
March 14, 2013Pearl Therapeutics Receives Award for...
More Press Releases